ProQR Therapeutics (PRQR) Net Margin Growth (5y) (2017 - 2026)

ProQR Therapeutics (PRQR) Net Margin Growth (5y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 ProQR Therapeutics 219.53 Mn 175.72 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -55,412.00
Dec 31, 2025 -5,227.00
Sep 30, 2025 -25,899.00
Jun 30, 2025 -21,050.00
Mar 31, 2025 -12,561.00
Dec 31, 2024 -10,733.00
Sep 30, 2024 -13,052.00
Jun 30, 2024 5,574.00
Mar 31, 2024 -7,603.00
Dec 31, 2023 -4,957.00
Sep 30, 2023 -34,055.00
Jun 30, 2023 -56,757.00
Mar 31, 2023 -139,725.00
Dec 31, 2022 -195,201.00
Sep 30, 2022 -286,462.00
Jun 30, 2022 -136,149.00
Mar 31, 2022 -135,401.00
Dec 31, 2021 -753,787.00
Sep 30, 2021 -162,300.00
Jun 30, 2021 -644,414.00